Centogene is a company specializing in diagnostics for rare diseases. Its stock price reflects the potential of its extensive database and diagnostic tests, but also the challenges of commercialization and achieving profitability.
Centogene is a life sciences company specializing in the diagnosis of rare hereditary diseases through genetic testing. We've categorized it as a "Medanalysis" company. The chart below shows how investors view the orphan disease diagnostics sector.
Centogene is a life sciences company specializing in diagnostics and research for rare genetic diseases. Its unique expertise makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Centogene compares to it.
The daily price change of Centogene N.V., a company specializing in rare disease diagnostics, reflects volatility in the MedTech sector. The indicator demonstrates sensitivity to demand for its genetic tests and partnerships with pharmaceutical companies.
Centogene specializes in diagnosing rare hereditary diseases using genetic testing. This is at the forefront of biotechnology. The chart below shows the volatility in this niche, reflecting the high potential and risks associated with CNTG's developments.
Centogene is a German company specializing in the diagnosis of rare inherited diseases. Its shares bring the dynamism of the European medtech sector to the US market. These international factors complicate the overall market volatility picture.
Centogene N.V.'s year-over-year performance tells the story of its work in the rare disease diagnostics market. Its market capitalization growth over the past 12 months reflects demand for its genetic tests and its extensive database, which helps pharmaceutical companies develop new drugs. Its valuation is a bet on the growth of personalized medicine.
Centogene is a company specializing in diagnosing rare diseases through genetic testing. Its unique database is its key asset. The chart shows how its leadership in this niche, partnerships with pharmaceutical companies, and path to profitability influence its growth.
Centogene, a diagnostic company specializing in rare diseases, reflects the growth of personalized medicine. Its ability to stay ahead of the market depends on increasing testing volumes and partnering with pharmaceutical companies, for whom its data is invaluable in developing new drugs.
Centogene is a company specializing in diagnostics for rare diseases. Its monthly growth is driven by the volume of tests it conducts and partnerships with pharmaceutical companies to support their clinical trials.
Centogene is a company specializing in the diagnosis of rare hereditary diseases. This genetic testing sector is key to the development of personalized medicine. The chart below shows how investors assessed the prospects of companies that help make accurate diagnoses in the most complex clinical cases.
Centogene N.V. is a company specializing in the diagnosis of rare hereditary diseases. Its business operates at the intersection of genetics and big data. The company's future depends on scientific advances and the implementation of its tests in clinical practice. A broader market graph allows us to assess how independent its unique niche has been from general economic cycles.
Centogene N.V. is a company specializing in diagnostics for rare inherited diseases. Its weekly stock price is driven by diagnostic testing volumes, partnerships with pharmaceutical companies, and progress in using its database for drug development.
Centogene specializes in diagnosing rare inherited diseases. The company operates at the intersection of genetics and big data. The chart below shows whether Centogene's share price fluctuations reflect its unique scientific developments and partnerships or whether they reflect general investor sentiment in the medical diagnostics sector.
Centogene is a company specializing in diagnostics for rare diseases. Its success depends on the adoption of its tests, not the state of the economy. This chart shows how the company's shares have a life of their own, often ignoring overall market fluctuations.
The market capitalization chart of Centogene, a company specializing in diagnostics for rare diseases, reflects its unique expertise. Its market valuation reflects how investors value its vast database and its ability to help pharmaceutical companies develop drugs. Its share price dynamics depend on its commercial success.
Centogene is a company specializing in diagnostics for rare diseases. Its market share in the medical diagnostics sector is small but significant within its niche. Its market capitalization reflects the value of its database and diagnostic tests, as well as its competitive position among other genetic labs.
The graph below shows the total value of the medical diagnostics sector. Centogene is a German company and a global leader in diagnosing rare hereditary diseases. The growth of this market you see is driven by breakthroughs in genetics. Centogene is at the forefront of this revolution, helping make diagnoses where previously impossible.
Centogene is a German company specializing in the diagnosis of rare hereditary diseases through genetic testing. Its market capitalization reflects its expertise in this field. The chart below shows the economic weight of the orphan disease diagnostics sector.
Centogene's book value is derived from its unique biodatabase, which links genetic information with clinical data on rare diseases, and its laboratories. The chart shows how this diagnostics company is investing in building its core asset—its database, which is a valuable resource for developing new drugs.
Centogene specializes in diagnosing rare diseases. The chart shows its share of real assets. These include its high-tech laboratories, equipped with state-of-the-art sequencing machines, which provide the foundation for genomic and biomarker analysis.
Centogene specializes in diagnosing rare hereditary diseases. Their business requires cutting-edge genetic laboratories equipped with expensive equipment. The book value chart shows the value of this high-tech and capital-intensive scientific infrastructure.
Centogene's balance sheet is their unique central laboratory in Germany, equipped with cutting-edge equipment for diagnosing rare diseases. The chart shows how the company has invested in this high-tech facility.
Centogene specializes in genetic diagnostics for rare diseases. Its assets include laboratories and a unique database. The chart shows how the market values this database and its scientific potential. The market valuation premium over book valuation represents the premium investors are willing to pay for leadership in this complex niche.
Centogene specializes in genetic diagnostics for rare diseases. Its core assets are its vast database, biobank, and scientific expertise. The chart clearly demonstrates the premium investors are willing to pay for these unique intangible assets, which significantly exceed the value of its physical laboratories and equipment.
Centogene specializes in genetic analysis, where value is created through technology and unique databases. This chart shows that the company's market valuation significantly exceeds the value of its laboratory equipment. Investors are paying for its intellectual property and leadership in rare disease diagnostics.
Centogene specializes in diagnosing rare inherited diseases. This chart shows how the company funds its research-based activities. Raising capital is necessary for expanding its biobank, developing new tests, and commercializing its diagnostic services globally.
Centogene specializes in diagnosing rare inherited diseases. Its business combines cutting-edge science with complex logistics to collect and analyze samples from around the world. This chart helps explain how the company funds its research and laboratory capacity expansion in this highly specialized area of medicine.
Centogene specializes in genetic diagnostics for rare diseases. This chart shows its financial structure. For a diagnostics company that requires investment in technology and databases, financial flexibility is essential. High debt can limit these opportunities and slow growth.
Centogene specializes in diagnosing rare genetic diseases. This chart shows the debt burden in the medical analytics sector. It helps understand how companies in this knowledge-intensive niche finance their research, processing vast amounts of genetic data, and expanding their knowledge base.
Centogene specializes in diagnosing rare hereditary diseases. This is a high-tech field of medicine that requires investment in databases and laboratory equipment. This graph of total market debt helps us understand how the company finances its unique technological assets—through profits or by borrowing for growth.
Centogene specializes in diagnosing rare inherited diseases using its extensive genetic and clinical database. This chart shows how investors value this data-driven business. The company's performance is driven by the number of tests it conducts and partnerships with pharmaceutical companies developing drugs for orphan diseases.
Centogene is a company specializing in the diagnosis of rare genetic diseases. It uses its extensive database and genetic analysis technology to assist doctors and pharmaceutical companies. This chart shows the average valuation for the medical analysis sector, reflecting how investors value data and expertise in the field of orphan diseases.
Centogene is a company specializing in the diagnosis of rare hereditary diseases. Demand for its services is fueled by advances in genetics and personalized medicine. This long-term trend makes its business less dependent on short-term economic cycles, as reflected in this chart. For Centogene, scientific breakthroughs and healthcare budgets are more important.
Centogene is a company specializing in the diagnosis of rare inherited diseases. It uses genetic testing to assist in diagnosis. This chart shows future revenue expectations, which depend on the growth of the genetic diagnostics market and partnerships with pharmaceutical companies.
%20P%2FE%20Centogene%20N.V.&width=1500&height=450&colorIndex=35&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Centogene-N.V. "Chart of the company's future (projected) P/E Centogene N.V.")
Centogene is a company focused on rare disease diagnostics using multi-omics technologies, including genetic testing. This chart shows general expectations for the healthcare sector. CNTG's position relative to the average reflects the market's perception of the value of its vast database and its ability to aid in the development of drugs for orphan diseases.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20&width=1500&height=450&colorIndex=36&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment "Future (projected) P/E graph of the market segment -")
Centogene N.V. is a company specializing in the diagnosis of rare inherited diseases. It uses its extensive database and multi-omics technologies to provide accurate diagnoses to patients worldwide. This chart of overall market expectations provides a backdrop for assessing the rapidly growing but complex market for genetic diagnostics and personalized medicine.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole "Chart of the future (projected) P/E of the market as a whole")
Centogene N.V. is a company specializing in the diagnosis of rare hereditary diseases through genetic testing. Its financial performance, shown in the graph, depends on the number of tests performed, partnerships with pharmaceutical companies, and the development of its biodatabase for scientific research.
Centogene specializes in diagnosing rare inherited diseases, using multi-omics technologies to analyze patient data. The company's services support diagnosis and drug development. This chart shows the overall profitability of the medical analytics sector, illustrating how advances in genetics and data analysis are transforming into commercially successful diagnostic solutions.
Centogene specializes in diagnosing rare hereditary diseases. Demand for its services is driven by advances in genetics and medicine, not by economic conditions. However, the overall market growth reflected in this chart creates a favorable investment climate, allowing the biotech companies with which Centogene partners to secure funding for their developments.
Centogene specializes in diagnosing rare hereditary diseases using its extensive genetic database. Revenue is based on the number of tests performed. This chart shows analysts' expectations for future revenue, driven by the growth of the genetic diagnostics market and the company's unique position in this sector.
%20profit%20of%20the%20company%20Centogene%20N.V.&width=1500&height=450&colorIndex=41&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Centogene-N.V. "Graph of future (projected) profit of the company Centogene N.V.")
Centogene specializes in diagnosing rare hereditary diseases using its extensive genetic database. The company's services support diagnosis and drug development. This chart shows profitability forecasts for the medical diagnostics sector, allowing one to assess how Centogene's unique expertise fits into the trends of personalized medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20&width=1500&height=450&colorIndex=42&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment "Graph of future (predicted) profits of companies in a market segment -")
Centogene specializes in diagnosing rare hereditary diseases. Demand for its services is supported by advances in genetics but is dependent on the budgets of healthcare systems and research institutes. The overall economic situation, reflected in the chart, may influence funding in this area.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole "Chart of future (predicted) profits of the market as a whole")
Centogene specializes in diagnosing rare hereditary diseases. This chart shows the market's appreciation for its unique expertise and vast genetic database. Its high multiple reflects confidence in the growth of personalized medicine and the potential for monetizing its data through partnerships with pharmaceutical companies.
Centogene specializes in diagnosing rare hereditary diseases using genetic testing. Revenue is generated through these diagnostic services. This chart for the medical diagnostics sector helps estimate the premium the market is willing to pay for Centogene's unique database and expertise in rare diseases.
Centogene specializes in diagnosing rare inherited diseases. The company uses its extensive genetic information database to assist with diagnoses and drug development. This market revenue valuation chart helps understand the value investors see in this unique combination of diagnostic services and data for the pharmaceutical industry.
Centogene is a company specializing in the diagnosis of rare inherited diseases. It uses its extensive database to analyze genomic information and assist in diagnosis. This chart shows how investors estimate future revenue from diagnostic tests. It reflects their expectations for the growth of the genetic diagnostics market and demand for its services.
%20P%2FS%20Centogene%20N.V.&width=1500&height=450&colorIndex=47&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Centogene-N.V. "The graph of the company's future (projected) P/S Centogene N.V.")
Centogene specializes in diagnosing rare inherited diseases using its extensive genetic database. The company's valuation reflects investors' belief in the growth of personalized medicine and the importance of its diagnostic platforms for patients and pharmaceutical companies developing drugs for rare diseases, but also the company's challenges in achieving profitability.
%20P%2FS%20market%20segment%20graph%20-%20&width=1500&height=450&colorIndex=48&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph "Future (projected) P/S market segment graph -")
Centogene N.V. specializes in genetic diagnostics for rare diseases. The company's growth is driven by the advancement of personalized medicine. This graph reflects general expectations, and Centogene represents a research-intensive sector shaping the future of healthcare.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole "Chart of the future (projected) P/S of the market as a whole")
Centogene specializes in diagnosing rare genetic diseases. This chart shows the company's revenue, which is generated by providing genetic testing for patients and diagnostic services to pharmaceutical companies developing drugs for orphan diseases.
Centogene (CNTG) is a company specializing in the diagnosis of rare inherited diseases. It uses a multi-omics approach, including genetic testing, to provide accurate diagnoses. This metric reflects revenue in the healthcare analytics sector. Centogene is at the forefront of personalized medicine, helping find answers for patients with rare diseases.
Centogene specializes in diagnosing rare hereditary diseases. Demand for its services is driven by medical needs, but the economic climate plays a role. This overall activity schedule influences healthcare system budgets and the willingness of insurance companies to cover the cost of expensive genetic tests that help make accurate diagnoses.
Centogene is a company specializing in the diagnosis of rare hereditary diseases using genetic testing. Its revenue depends on the number of tests performed and partnerships with pharmaceutical companies. This chart shows analyst revenue expectations, which is an indicator of the growth of the genetic diagnostics market and the adoption of its services by the medical community.
%20sales%20of%20the%20company%20Centogene%20N.V.&width=1500&height=450&colorIndex=53&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Centogene-N.V. "Schedule of future (projected) sales of the company Centogene N.V.")
Centogene specializes in diagnosing rare genetic diseases. The forecast in this chart segments future revenue, likely into revenue from diagnostic tests and partnerships with pharmaceutical companies. This allows us to estimate which portion of their business, based on unique genetic data, will grow faster.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20&width=1500&height=450&colorIndex=54&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment "Schedule of future (projected) sales of companies in the market segment -")
Centogene specializes in diagnosing rare hereditary diseases. Demand for its services is growing as personalized medicine advances. This chart illustrates general economic trends, but for Centogene, the key driver is scientific advances in genetics and the growing understanding of how DNA diagnostics can help treat thousands of rare diseases.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole "Schedule of future (predicted) sales of the market as a whole")
Centogene specializes in genetic diagnostics for rare hereditary diseases. The company's profitability depends on the number of tests performed and partnerships with pharmaceutical companies, for whom accurate diagnosis is critical. The chart shows how the company monetizes its unique expertise and vast genetic database.
Centogene is a company specializing in diagnosing rare inherited diseases using genetic testing and data analysis. This chart shows the profitability of its diagnostics business. Success depends on the volume of tests performed, partnerships with pharmaceutical companies, and the value of its unique rare disease database.
Centogene specializes in diagnosing rare hereditary diseases. Demand for its expensive tests depends on the willingness of insurance companies and healthcare systems to pay for them. This overall profitability chart reflects the financial strength of these payers. A stable economy allows them to allocate budgets for advanced genetic diagnostics.
Centogene specializes in diagnosing rare hereditary diseases using genetic analysis. Its business operates at the intersection of medicine and big data. This chart shows the size of its team of scientists, geneticists, and bioinformaticians, who are the company's key asset, transforming complex data into useful clinical information.
Centogene specializes in diagnosing rare hereditary diseases. Its business relies on high-tech laboratories and the analysis of complex genetic data. This chart shows the number of scientists, geneticists, and laboratory technicians required to provide unique diagnostic services that help make accurate diagnoses for thousands of patients worldwide.
Centogene N.V. specializes in diagnosing rare hereditary diseases. This chart, showing employment in the medical analytics sector, demonstrates the growing importance of genetic data in medicine. For Centogene, the growing number of geneticists and bioinformaticians indicates an expanding market and increased demand for their unique database and diagnostic tests.
Centogene specializes in diagnosing rare hereditary diseases. Demand for its services depends on awareness and access to genetic testing. The growth in overall employment, shown in this graph, supports the healthcare system through insurance premiums, allowing more patients to access the advanced diagnostics offered by Centogene.
Centogene (CNTG) specializes in diagnosing rare diseases using its database and AI. It's a hybrid of medicine and big data. This metric reflects how much the market values their unique database and technology platform (intellectual capital) compared to their staff of lab technicians and geneticists (labor). Data scalability is key to achieving high employee valuations.
%20of%20the%20company%20Centogene%20N.V.%20(CNTG)&width=1500&height=450&colorIndex=63&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Centogene-N.V.-CNTG "Chart of market capitalization per employee (in thousands of dollars) of the company Centogene N.V. (CNTG)")
Centogene specializes in diagnosing rare hereditary diseases. The company's value lies in its unique database linking genetic information with clinical data. This metric reflects how the market values this valuable information asset, created and analyzed by its team of experts.
%20by%20market%20segment%20-%20&width=1500&height=450&colorIndex=64&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment "Market capitalization per employee (in thousands of dollars) by market segment -")
Centogene specializes in diagnosing rare hereditary diseases. The company has an extensive genetic database. This chart for Centogene illustrates how, in the medical diagnostics industry, value is created not only by lab tests but also by unique data, enabling high ROE through intangible assets.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market "Market capitalization per employee (in thousands of dollars) for the overall market")
Centogene specializes in complex diagnostics of rare hereditary diseases. Their business consists of a high-tech laboratory and a massive database. This graph demonstrates how efficiently their processes are automated. The high efficiency per employee demonstrates that their unique expertise and technology allow them to conduct expensive tests with high profitability.
%20Chart%20Centogene%20N.V.%20(CNTG)&width=1500&height=450&colorIndex=66&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Centogene-N.V.-CNTG "Company Profit Per Employee (in thousands of dollars) Chart Centogene N.V. (CNTG)")
Centogene specializes in diagnosing rare hereditary diseases. In the field of genetic analysis, the qualifications of laboratory technicians, geneticists, and bioinformaticians are key. This metric demonstrates how effectively the company utilizes its unique human capital to generate profits, which is an indicator of its technological leadership.
%20in%20the%20market%20segment%20-%20&width=1500&height=450&colorIndex=67&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment "Chart of profit per employee (in thousands of dollars) in the market segment -")
Centogene is a company specializing in rare disease diagnostics. They use multi-omics analysis (including genetics) to assist physicians and pharmaceutical companies. This chart, showing average earnings per employee across all industries, helps investors assess how highly profitable the medical diagnostics sector, where precision and R&D are crucial, is in terms of profitability per specialist.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Centogene specializes in diagnosing rare hereditary diseases. Its revenue per employee reflects the value of its unique database and laboratory services. The chart shows how the company helps doctors and pharmaceutical companies worldwide by providing accurate and rapid diagnostics based on genetic analysis.
&width=1500&height=450&colorIndex=69&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Sales-chart-per-company-employee-Centogene-N.V.-CNTG "Sales chart per company employee Centogene N.V. (CNTG)")
Centogene (CNTG) is a company specializing in diagnosing rare hereditary diseases using its extensive genetic database. This chart shows the average revenue per employee in the segment. It helps assess how effectively Centogene utilizes its scientific and laboratory staff to generate revenue from diagnostic tests.
Centogene (CNTG) is a company specializing in diagnostics for rare inherited diseases. They utilize their extensive genetic database and biobank for R&D and diagnostics. This metric reflects how effectively their laboratories and team of data scientists generate revenue from performing complex genetic tests for pharmaceutical companies and patients.
Centogene (CNTG) specializes in diagnosing rare inherited diseases. Despite its technological strength, the company is struggling to achieve profitability. This chart shows short interest. A rise in the indicator may reflect investor concerns about high cash burn, difficulties obtaining reimbursement for tests, or the intense competition in the genetic diagnostics market. (347)
&width=1500&height=450&colorIndex=72&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Centogene-N.V.-CNTG "Short Shares Chart for the Company Centogene N.V. (CNTG)")
Centogene (CNTG) specializes in genetic diagnostics for rare diseases, using its database to accelerate drug discovery. The chart below shows the overall short position in the medical diagnostics sector. It reflects whether investors expect lower test prices or increased competition in the genetic analysis field.
Centogene specializes in diagnosing rare diseases, partnering with pharmaceutical companies. This chart illustrates the overall market pessimism. Investors fear that during the crisis, "big pharma" (CNTG's clients) will cut their R&D budgets, leading to a decline in demand for diagnostic and research services.
Centogene (CNTG) is a German company specializing in the diagnosis of rare hereditary diseases. Data analysis and genetics are at the core of their strategy. This chart measures the rate of price change. It helps identify when the stock is overheated (above 70) on partnership news or oversold (below 30) due to slow earnings growth.
&width=1500&height=450&colorIndex=75&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Centogene-N.V.-CNTG "RSI 14 indicator chart for the company's stock Centogene N.V. (CNTG)")
Centogene is a German company specializing in the diagnosis of rare hereditary diseases. They use genetic analysis (sequencing) to identify the causes of diseases. This chart measures the overall momentum in the medical diagnostics sector. It helps determine whether the entire segment is oversold after the pandemic boom.
For Centogene, a biotech company in R&D, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is turned off, and cash-burning companies face a liquidity crisis.
Centogene is a German company specializing in diagnostics for rare inherited diseases using multiomics analytics and the world's largest biodatabase. This chart shows the analyst consensus: their average 12-month target price for the stock, based on the company's growing testing volumes and partnerships with pharmaceutical companies.
&width=1500&height=450&colorIndex=78&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CNTG-Centogene-N.V. "A chart showing analyst consensus forecasts for the expected stock price. CNTG (Centogene N.V.)")
Centogene is a German company specializing in diagnostics for rare hereditary diseases. Their business is a combination of tests and extensive biodata. This chart shows how far the current share price differs from the "fair" value predicted by analysts. It reflects their belief in the growing demand for genetic diagnostics and their ability to monetize their unique data.
&width=1500&height=450&colorIndex=79&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CNTG-Centogene-N.V. "A chart showing the difference between the consensus forecast and the actual stock price. CNTG (Centogene N.V.)")
Centogene is a medical "detective," specializing in diagnosing rare hereditary diseases through genetic analysis. This chart shows analysts' overall expectations for the entire medical testing sector. It reflects whether experts believe the smart genomic diagnostics market will grow or whether they expect a decline in R&D spending.
Centogene is a company specializing in the diagnosis of rare inherited diseases using genetic testing (DNA). This chart shows overall market sentiment. For Centogene, which operates in the "defensive" healthcare sector, general optimism is important, but their growth depends more on the adoption of their tests in clinical practice and acceptance by insurance companies.
Centogene is a diagnostic detective for rare diseases. Their stronghold is one of the world's largest genetic databases (biobank) for orphan diseases. This chart is a summary indicator of their data model. It reflects not only their current testing revenue but also (more importantly) the market's valuation of their partner R&D potential, which resides in their unique biobank.
Centogene specializes in medical detective work—diagnosing rare hereditary diseases. Their business is built on a unique genetic database. This high-tech medical analytics. This chart compares their composite index to the sector, allowing you to assess how their niche, science-intensive model outperforms or underperforms the competition.
Centogene is a company specializing in diagnosing rare diseases using genetic data. Based in Germany, this chart, which reflects the market average, serves as a backdrop. It helps assess how CNTG, with its unique database, compares to overall macroeconomic trends in diagnostics.
